Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (HIV) or hepatitis C

A technology for human immunodeficiency and blood diseases, applied in drug combinations, active ingredients of hydroxyl compounds, antiviral agents, etc.

Inactive Publication Date: 2012-05-16
萨利门·埃尔·克塔尼 +1
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Thus, known conventional therapies have significant drawbacks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (HIV) or hepatitis C
  • Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (HIV) or hepatitis C
  • Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (HIV) or hepatitis C

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0044] Composition

[0045] The composition according to the invention comprises the ingredients listed in the table below, ideally in the proportions mentioned therein:

[0046]

[0047]

[0048] Preparation

[0049] Combine these ingredients according to the following method:

[0050] At room temperature and ambient pressure, 1.5 g of menthol crystals were placed in the container.

[0051] 4 g of pure alcohol, preferably 95° ethanol, is introduced into the vessel to dissolve the menthol crystals and nigella oil (when added).

[0052] The whole was left to stand for 5 minutes, then stirred to aid dissolution.

[0053] 2 g of edible sublimed sulfur was incorporated into the resulting mixture.

[0054] Then add 5g of GAFT juice. The juice was previously prepared by soaking 1 kg of dried leaves and stems of GAFT in 3.5 liters of water for 20 hours at room temperature. The mixture is then distilled by heating at low temperature and collecting the vapors formed in a ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a plant composition for the treatment or prevention of viral blood-borne diseases such as the diseases caused by the human immunodeficiency virus (HIV) or hepatitis C. According to the invention, the composition mainly includes flower of sulphur, a plant which contains catechins and a tannin agent, as well as a pharmaceutically acceptable medium. The invention also relates to the method for manufacturing said composition. The invention can be used in the field of treating or preventing viral blood-borne diseases such as the diseases caused by the human immunodeficiency virus (HIV) or hepatitis C.

Description

technical field [0001] The present invention relates to plant-based compositions for the treatment and prevention of viral blood diseases such as those caused by human immunodeficiency virus (HIV) or hepatitis C. Background technique [0002] Symptoms associated with the disease are delayed in HIV carriers because they do not appear until two to ten years after their infection. During this period, with no visible disease effects, carriers may have unknowingly transmitted the virus during unprotected intercourse, through blood contamination, or through mother-to-child transmission. Therefore, this long incubation period is partly responsible for the epidemic spread of the disease. [0003] Furthermore, there is currently no vaccine that provides protection against HIV, and existing known treatments, such as retroviral triple therapy, are somewhat effective but not curative. [0004] Furthermore, these drugs are generally not prescribed at the onset of seropositivity because...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/73A61K36/74A61P31/12A61K35/02
CPCA61K36/71A61K36/74A61K31/353A61K31/05A61K35/02A61K9/0095A61K36/73A61K45/06A61P1/16A61P31/00A61P31/12A61P31/14A61P31/18A61P43/00A61K2300/00
Inventor 萨利门·埃尔·克塔尼
Owner 萨利门·埃尔·克塔尼
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com